Patient Guide: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 81 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05263934
Status: 🟢 Enrolling Now
Condition: Granulomatosis with Polyangiitis, Systemic Vasculitis, Churg-Strauss Syndrome
Phase: PHASE3

Where You Can Participate

This study is available at 81 locations across the country.

Top locations include:
  • • Denver, Colorado
  • • Gainesville, Florida
  • • Rochester, Minnesota
  • • And 78 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Join Clinical Trial NCTNCT05263934

How to Join This Clinical Trial - NCTNCT05263934

Learn how to participate in this PHASE3 trial studying an investigational therapy for Granulomatosis with Polyangiitis, Systemic Vasculitis, Churg-Strauss Syndrome. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Granulomatosis with Polyangiitis, Systemic Vasculitis, Churg-Strauss Syndrome. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Granulomatosis with Polyangiitis, Systemic Vasculitis, Churg-Strauss Syndrome
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05263934 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 81 locations. Find a study site near you:

Clinical Research Site

Denver, Colorado 80206 - United States

Status: RECRUITING

Clinical Research Site

Gainesville, Florida 32610 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Manhasset, New York 11030 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10021 - United States

Status: RECRUITING

Clinical Research Site

Charlotte, North Carolina 28211 - United States

Status: RECRUITING

Clinical Research Site

Tulsa, Oklahoma 74136 - United States

Status: RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: RECRUITING

Clinical Research Site

Pittsburgh, Pennsylvania 15261 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37208 - United States

Status: WITHDRAWN

And 71 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Granulomatosis with Polyangiitis, Systemic Vasculitis, Churg-Strauss Syndrome:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships